Your session is about to expire
← Back to Search
Assessment Tool for Cancer Care Planning
Study Summary
This trial is studying an assessment tool to help doctors plan treatment for older patients with cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Geriatric Assessment Tool
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How widely distributed is this medical trial?
"This trial is available at the Wake Forest University Comprehensive Cancer Center in Winston-Salem, North carolina; Yale Cancer Center in New Haven, Connecticut; James P. Wilmot Cancer Center at University of Rochester Medical center in Rochester, NY and 8 other medical sites across the country."
Who might be a likely candidate for participation in this experiment?
"This clinical trial seeks 750 participants with cancer between the ages of 65 and 120. To join, they must have a confirmed diagnosis, be undergoing chemotherapy before beginning this study, comprehend English well enough to understand instructions given to them by personnel onsite, not previously enrolled in this research project and currently uninvolved in any other phase I trials."
Is this medical trial open to those aged 65 or older?
"This trial allows individuals aged 65 to 120 years old to register. There are 4 trials meant for youths, and 43 options available for the elderly population."
Is there availability for participants in this experiment?
"Per the information on clinicaltrials.gov, this particular study is no longer looking for participants as its last edit was made in March of 2022. However, 45 other trials are currently open and recruiting new patients."
Share this study with friends
Copy Link
Messenger